Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lippert

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Emerging Infectious Diseases|June 8, 2021
Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021Pinkus Tober-Lau, Tatjana Schwarz, David Hillus, et al.
The Lancet. Respiratory Medicine|August 15, 2021
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort studyDavid Hillus, Tatjana Schwarz, Pinkus Tober-Lau, et al.
Emerging Infectious Diseases|June 8, 2021
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, GermanyTatjana Schwarz, Pinkus Tober-Lau, David Hillus, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Cell Systems|June 17, 2021
A time-resolved proteomic and prognostic map of COVID-19Vadim Demichev, Pinkus Tober-Lau, Oliver Lemke, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
PLOS Digital Health|February 22, 2023
A proteomic survival predictor for COVID-19 patients in intensive careVadim Demichev, Pinkus Tober-Lau, Tatiana Nazarenko, et al.
Human Molecular Genetics|July 18, 2022
Detailed stratified GWAS analysis for severe COVID-19 in four European populationsFrauke Degenhardt, David Ellinghaus, Simonas Juzenas, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Emerging Infectious Diseases|June 8, 2021
Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021Pinkus Tober-Lau, Tatjana Schwarz, David Hillus, et al.
The Lancet. Respiratory Medicine|August 15, 2021
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort studyDavid Hillus, Tatjana Schwarz, Pinkus Tober-Lau, et al.
Emerging Infectious Diseases|June 8, 2021
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, GermanyTatjana Schwarz, Pinkus Tober-Lau, David Hillus, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Cell Systems|June 17, 2021
A time-resolved proteomic and prognostic map of COVID-19Vadim Demichev, Pinkus Tober-Lau, Oliver Lemke, et al.
Eclinicalmedicine|September 7, 2021
Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01January Weiner, Phillip Suwalski, Manuel Holtgrewe, et al.
PLOS Digital Health|February 22, 2023
A proteomic survival predictor for COVID-19 patients in intensive careVadim Demichev, Pinkus Tober-Lau, Tatiana Nazarenko, et al.
Human Molecular Genetics|July 18, 2022
Detailed stratified GWAS analysis for severe COVID-19 in four European populationsFrauke Degenhardt, David Ellinghaus, Simonas Juzenas, et al.
Pageof 9